$0.00
(0.00%)
| Today's Open | $3.15 |
|---|---|
| Previous Close | $3.13 |
| Daily Range | $3.08 - $3.24 |
| 52-Week Range | $1.95 - $4.50 |
| Market Cap | $323.9M |
| P/E Ratio | -10.43 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 673,633 |
| Average Daily Volume | 661,264 |
| Current FY EPS | -$0.27 |
Sector
Healthcare
Industry
Drugs
Dyax Corp. (DYAX) Description
A biopharmaceutical company focused on the discovery, development and commercialization of novel biotherapeutics for unmet medical needs, with an emphasis on oncology and inflammatory indications. Website: http://www.dyax.com/
News & Commentary
Ovarian Cancer Drug Half Way There
Amgen's trebananib delays progression, but survival data is key.Dyax HAE Allies? Awards Program Launches on Second Annual Hereditary Angioedema (HAE) Day – a Global
3 Biggest Biotech Crashes in April
When biotechs fall, they fall hard. These three fell the hardest in April.DYAX's Top Competitors
(3.19%)
(2.44%)
(1.78%)
(1.47%)